All News NutraLife BioSciences, Inc.

Equities

NLBS

US67098B1070

Delayed OTC Markets Other stock markets 01:45:42 2024-03-01 pm EST			5-day change	1st Jan Change
0.0001 ^USD	-66.67%		-.--%	-50.00%

2023	NutraLife BioSciences, Inc. (OTCPK : NLBS) entered into a Stock Exchange Agreement to acquire Healthcare Concierges USA, Inc. from Mrugesh Patel, Pinal Kerai and Aysha Khan for 2 million.	CI
2022	NutraLife BioSciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

NutraLife Biosciences (OTC: NLBS) Releases Q4 2022 Shareholder Update and Announces the Acquisition of Healthcare Concierges USA	23-03-01	AQ
NUTRALIFE BIOSCIENCES, INC : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	23-02-28	AQ
NutraLife BioSciences, Inc. (OTCPK : NLBS) entered into a Stock Exchange Agreement to acquire Healthcare Concierges USA, Inc. from Mrugesh Patel, Pinal Kerai and Aysha Khan for 2 million.	23-02-27	CI
NUTRALIFE BIOSCIENCES, INC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	22-11-21	AQ
NutraLife BioSciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-21	CI
NutraLife Biosciences (OTC: NLBS) Releases Q4 2022 Shareholder Update	22-11-17	AQ
NutraLife Biosciences Launches a Clinically Tested Focus Stimulant Under a Master Distribution Agreement	22-10-27	AQ
NutraLife Biosciences, Inc. Executes Master Distribution Agreement with Whole Foods Full Spectrum Processing	22-10-27	CI
NUTRALIFE BIOSCIENCES, INC : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)	22-10-12	AQ
NutraLife BioSciences, Inc. announced that it has received $0.04 million in funding	22-09-11	CI
NUTRALIFE BIOSCIENCES, INC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	22-08-22	AQ
NutraLife BioSciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-22	CI
NUTRALIFE BIOSCIENCES, INC : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)	22-08-17	AQ
Nutralife Biosciences Executes a Joint Venture Agreement With Emergent Health Corporation for the Co-Production, Co-Marketing, and Distribution of Emergent’s Line of Regenerative, and Other Health-Related Nutraceutical, Skincare and Pet Pro	22-07-08	AQ
Nutralife Biosciences Executes a Joint Venture Agreement With Emergent Health Corporation for the Co-Production, Co-Marketing, and Distribution of Emergent’s Line of Regenerative, and Other Health-Related Nutraceutical, Skincare and Pet Pro	22-07-08	CI
NutraLife Biosciences Inc. Engages CFN Media to Reach, Attract Retail, Accredited & Institutional Investors	22-06-15	AQ
NUTRALIFE BIOSCIENCES, INC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	22-05-23	AQ
NutraLife BioSciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-23	CI
NUTRALIFE BIOSCIENCES, INC Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	22-04-11	AQ
NutraLife BioSciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-11	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News NutraLife BioSciences, Inc.

Equities

NLBS

US67098B1070

All News

Filters